BridgeMD
New treatment option for Urinary Retention
Official title Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
ClinicalTrials.gov ID: NCT05657990
What this study is testing
What is Tamsulosin?
Tamsulosin is an investigational medicine, given as an once-daily, being studied as a potential treatment for urinary retention.
Also referred to as Flomax.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older, men only
You may be able to join if
- Males
- ≥55 years old
- Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.
- Surgery scheduled more than 7 days from the time of consent
You likely can't join if
- Using Tamsulosin already
- Known allergy to Tamsulosin or sulfa drugs
- Current use of Boceprevir
- Resting systolic blood pressure \<100
- Orthostatic hypotension of \>20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at...
- Known history of hypotension
See the full eligibility criteria
- Males
- ≥55 years old
- Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.
- Surgery scheduled more than 7 days from the time of consent
- Using Tamsulosin already
- Known allergy to Tamsulosin or sulfa drugs
- Current use of Boceprevir
- Resting systolic blood pressure \<100
- Orthostatic hypotension of \>20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consent
- Known history of hypotension
- Known diagnosis of congestive heart failure (CHF) and valvular heart disease
- History of prior prostate surgery (prostatectomy, trans-urethral resection)
The study team makes the final eligibility decision.
Where it's taking place
- Brick, New Jersey, United States
- Manahawkin, New Jersey, United States
- Neptune City, New Jersey, United States
- Red Bank, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brick, New Jersey, United States; Manahawkin, New Jersey, United States; Neptune City, New Jersey, United States; Red Bank, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.